Title of article
A New Perspective in the Management of Graves’ Hyperthyroidism
Author/Authors
Azizi, Fereidoun Endocrine Research Center - Research Institute for Endocrine Sciences - Shahid Beheshti University of Medical Sciences, Tehran, Iran
Pages
5
From page
1
To page
5
Abstract
Inappropriately high synthesis and secretion of hormones
by the thyroid gland causes hyperthyroidism.
This disease has multiple etiologies, presentations, and
manifestations and requires various management strategies.
Graves’ hyperthyroidism is an autoimmune disease
caused bythe stimulation of thyrotropin (TSH) receptor via
TSH receptor antibodies (TRAb), resulting in the increased
thyroid hormone production and release (1). The management
of Graves’ hyperthyroidism involves complex decision
making on diagnosis, treatment strategy, and proper
follow-up (2).
Keywords
Antithyroid Drugs , Graves’ Disease , Methimazole , Treatment
Journal title
International Journal of Endocrinology and Metabolism
Serial Year
2020
Record number
2611823
Link To Document